Abstract
ACCELRYS, THE RESEARCH SOFTware subsidiary of Pharmacopeia, declared a victory in its quest to conquer the combined bioinformatics, cheminformatics, molecular modeling, and research knowledge management market with Accelrys World, its first major user conference in San Diego last month. The two-year-old company showcased two PCfronted networks—one for materials science and one for life sciences—built from a comprehensive range of software amassed through several acquisitions. On hand were computational chemistry managers and R&D chiefs with Pfizer, Eli Lilly, GlaxoSmithKline, Unilever, Dow Chemical, BP Chemicals, General Motors, and others. All use Accelrys software. It was a tough crowd—researchers, by their own admission, are among the most hard-to-please computer users. They tend to be renegades, convinced that their special needs are impossible for corporate information technology departments to comprehend. They have a high level of skepticism regarding a software vendor's claim that it can deliver a ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
